A novel apoptosis pathway activated by the carboxyl terminus of p21

Blood

Volumn 105, Issue 3, 2005, Pages 1187-1194

  Dong, Chen ^a   Li, Qing ^a   Lyu, Shu Chen ^a   Krensky, Alan M ^a   Clayberger, Carol ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; APAMIN; CALCIUM CHANNEL BLOCKING AGENT; CASPASE; CYTOCHROME C OXIDASE; ECONAZOLE; EDETIC ACID; EGTAZIC ACID; GLYCYLARGINYLLYSYLARGINYLARGINYLGLUTAMINYLTHREONYLSERYLMETHIONYLTHREONYLASPARTYLPHENYLALANYLTYROSYLHISTIDYLSERYLLYSYLARGINYLARGINYLLEUCYLISOLEUCYLPHENYLALANYLSERYLARGINYLTYROSYLISOLEUCYLARGINYLSERINE; GRANULYSIN; IBERIOTOXIN; MYXOTHIAZOL; N [(2,6 DIMETHYLPHENYL)CARBAMOYLMETHYL]TRIMETHYLAMMONIUM; NICARDIPINE; PENTAPEPTIDE; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CYANIDE; PROTEIN P21; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); ROTENONE; SODIUM CHANNEL BLOCKING AGENT; STAUROSPORINE; STIGMATELLIN; SUCCINATE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL POPULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN TARGETING;

EID: 12844262761     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-06-2188     Document Type: Article

References (52)

1. Marsden VS, Strasser A. Control of apoptosis in the immune system: Bcl-2, BH3-only proteins and more. Annu Rev Immunol. 2003;21:71-105.
2. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 1993;75:805-816.
3. el-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell. 1993;75:817-825.
4. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res. 1994;211:90-98.
5. Dotto GP. p21 (WAF1/Cip): more than a break to the cell cycle? Biochim Biophys Acta. 2000;1471:43-56.
6. Kralj M, Husnjak K, Korbler T, Paveli J. Endogenous p21WAF1/Cip1 status predicts the response of human tumor cell to wild-type p53 and p21WAF1/Cip1 overexpression. Cancer Gene Ther. 2003;10:457-467.
7. Gartel AL, Tyner AL. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther. 2002;1:639-649.
8. Cip1/WAF1 in monocytic differentiation. EMBO J. 1999;18:1223-1234.
9. Raderschall E, Bazarov A, Cao J, et al. Formation of higher-order nuclear Rad51 structures is functionally linked to p21 expression and protection from DNA damage-induced apoptosis. J Cell Sci. 2002;115:153-164.
10. Mutoh M, Lung FD, Long YQ, Roller PP, Sikorski RS, O'Connor PM. A p21 (Waf1/Cip1) carboxyl-terminal peptide exhibited cyclin-dependent kinase-inhibitory activity and cytotoxicity when introduced into human cells. Cancer Res. 1999;59:3480-3488.
11. Dong C, Lyu SC, Krensky AM, Clayberger C. DQ 65-79, a peptide derived from HLA class II, mimics p21 to block T cell proliferation. J Immunol. 2003;171:5064-5070.
12. Wang Z, Choice E, Kaspar A, et al. Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin. J Immunol. 2000;165:1486-1490.
13. Pardo J, Perez-Galan P, Gamen S, et al. A role of the mitochondrial apoptosis-inducing factor in granulysin-induced apoptosis. J Immunol. 2001;167:1222-1229.
14. Farkas DL, Wei MD, Febbroriello P, Carson JH, Loew LM. Simultaneous imaging of cell and mitochondrial membrane potentials. Biophys J. 1989;56:1053-1069.
15. Ehrenberg B, Montana V, Wei MD, Wuskell JP, Loew LM. Membrane potential can be determined in individual cells from the nernstian distribution of cationic dyes. Biophys J. 1988;53:785-794.
16. 6(3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells: implications for studies on mitochondrial functionality during apoptosis. FEBS Lett. 1997;411:77-82.
17. Marchetti P, Susin SA, Decaudin D, et al. Apoptosis-associated derangement of mitochondrial function in cells lacking mitochondrial DNA. Cancer Res. 1996;56:2033-2038.
18. Housman D, Jacobs-Lorena M, Rajbhandary UL, Lodish HF. Initiation of haemoglobin synthesis by methionyl-rRNA. Nature. 1970;227:913-918.
19. Sabath DE, Cross ST, Mamiya LY. An improved method for detecting red cells with hemoglobin H inclusions that does not require glass capillary tubes. Clin Lab Haematol. 2003;25:87-91.
20. Krohn AJ, Wahlbrink T, Prehn JH. Mitochondrial depolarization is not required for neuronal apoptosis. J Neurosci. 1999;19:7394-7404.
21. Renner K, Amberger A, Konwalinka G, Kofler R, Gnaiger E. Changes of mitochondrial respiration, mitochondrial content and cell size after induction of apoptosis in leukemia cells. Biochim Biophys Acta. 2003;1642:115-123.
22. Finucane DM, Waterhouse NJ, Amarante-Mendes GP, Cotter TG, Green DR. Collapse of the inner mitochondrial transmembrane potential is not required for apoptosis of HL60 cells. Exp Cell Res. 1999;251:166-174.
23. + efflux in the activation of apoptosis. J Biol Chem. 1997;272:32436-32442.
24. + suppresses the activation of apoptosis in lymphocytes. J Biol Chem. 1997;272:30567-30576.
25. Kaspar AA, Okada S, Kumar J, et al. A distinct pathway of cell-mediated apoptosis initiated by granulysin. J Immunol. 2001;167:350-356.
26. Okada S, Li Q, Whitin J, Clayberger C, Krensky AM. Intracellular mediators of granulysis-induced cell death. J Immunol. 2003;171:2556-2562.
27. Suzuki YS, Forman HJ, Sevanian A. Oxidants as stimulators of signal transduction. Free Radical Biol Med. 1997;22:269-285.
28. Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem. 1992;59:1609-1623.
29. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A. 1993;90:7915-7922.
30. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 1993;262:689-695.
31. Jenner P. Oxidative damage in neurodegenera-tive disease. Lancet. 1994;344:796-798.
32. Shigenaga MK, Hagen TM, Ames BN. Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci U S A. 1994;91:10771-10778.
33. Parthasarathi K, Ichimura H, Quadri S, Issekutz A, Bhattacharya J. Mitochondrial reactive oxygen species regulate spatial profile of proinflammatory responses in lung venular capillaries. J Immunol. 2002;169:7078-7086.
34. Waypa GB, Marks JD, Mack MM, Boriboun C, Mungai PT, Schumacker PT. Mitochondrial reactive oxygen species trigger calcium increases during hypoxia in pulmonary arterial myocytes. Circ Res. 2002;91:719-726.
35. Tan S, Sagara Y, Liu Y, Maher P, Schubert D. The regulation of reactive oxygen species production during programmed cell death. J Cell Biol. 1998;141:1423-1432.
36. + concentrations. J Biol Chem. 2000;275:27838-27844.
37. Goldstein JC, Waterhouse NJ, Juin P, Evan GI, Green DR. The coordinate release of cytochrome C during apoptosis is rapid, complete and kinetically invariant. Nat Cell Biol. 2000;2:156-162.
38. Bossy-Wetzel E, Newmeyer DD, Green DR. Mitochondrial cytochnome C release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J. 1998;17:37-49.
39. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome C. Cell. 1996;86:147-157.
40. Li P, Nijhawan D, Budihardjo I, et al. Cytochrome C and dATP-dependent formation of Apaf-1/ caspase-9 complex initiates an apoptotic protease cascade. Cell. 1997;91:479-489.
41. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome C-dependent activation of caspase-3. Cell. 1997;90:405-413.
42. Belmokhtar CA, Hillion J, Dudognon C, et al. Apoptosome-independent pathway for apoptosis-Biochemical analysis of APAF-1 defects and biological outcomes. J Biol Chem. 2003;278:29571-29580.
43. Denecker G, Vercammen D, Declercq W, Vandenabeele P. Apoptotic and necrotic cell death induced by death domain receptors. Cell Mol Life Sci. 2001;58:356-370.
44. +, cell shrinkage, and mitochondrial membrane potential during lymphocyte apoptosis. J Biol Chem. 1999;274:21953-21962.
45. WAF1/CIP1/SDI1 protein in phorbol ester-induced G2/M arrest. J Biol Chem. 1996;271:29556-29560.
46. Levkau B, Koyama H, Raines EW, et al. Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: a role of a caspase cascade. Mol Cell. 1998;1:553-563.
47. Waf1/Cip1 converts cancer cells from growth arrest to undergoing apoptosis. Oncogene. 1999;18:1131-1138.
48. WAF1. Curr Biol. 1997;7:71-80.
49. WAF1-derived peptides linked to an internalization peptide inhibit human cancer cell growth. Cancer Res. 1997;57:1442-1146.
50. Vives E, Brodin P, Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nuleus. J Biol Chem. 1997;272:16010-16017.
51. Joliot A, Pernelle C, Deagostini-Bazin H, Prochiantz A. Antennapedia homeobox peptide regulates neural morphogenesis. Proc Natl Acad Sci U S A. 1991;88:1864-1868.
52. Lundberg P, Langel U. A brief introduction to cell-penetrating peptides. J Mol Recognit. 2003;16:227-233.